A novel empeROR of pancreatic malignancy.

Autor: Peñuelas-Haro I; Department of Pathology and Experimental Therapy, School of Medicine, University of Barcelona (UB), Barcelona, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Espinet E; Department of Pathology and Experimental Therapy, School of Medicine, University of Barcelona (UB), Barcelona, Spain.; Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.
Jazyk: angličtina
Zdroj: The EMBO journal [EMBO J] 2023 Jul 17; Vol. 42 (14), pp. e114282. Date of Electronic Publication: 2023 Jun 14.
DOI: 10.15252/embj.2023114282
Abstrakt: How pancreatic cancer cells acquire tumor initiating capacities remains poorly understood. A recent study by Yamazaki et al (2023) uncovers a crucial, targetable role of tyrosine kinase-like orphan receptor (ROR1) in PDAC tumor formation and progression.
(© 2023 The Authors. Published under the terms of the CC BY 4.0 license.)
Databáze: MEDLINE
Externí odkaz: